Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
about
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer diseaseAmyloid-associated depression: a prodromal depression of Alzheimer disease?Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient dietApoE promotes the proteolytic degradation of AbetaValsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer diseaseNSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoBrain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosisInflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's diseaseImmunotherapy targeting pyroglutamate-3 Aβ: prospects and challengesMouse Genetic Models of Human Brain DisordersA systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseEntorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age.Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's diseaseDietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationDynamin 1 regulates amyloid generation through modulation of BACE-1Widespread protein aggregation as an inherent part of aging in C. elegansEnhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading EnzymeInterictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathologyPotent memapsin 2 (β-secretase) inhibitors: Design, synthesis, protein-ligand X-ray structure, and in vivo evaluationEffects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human agingRapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil.Defining the toxicology of agingAnti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's diseaseFerulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic miceVitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic miceAggregate-depleted brain fails to induce Aβ deposition in a mouse model of Alzheimer's diseaseLoss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's diseaseCorrelations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse modelGWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Paternal spatial training enhances offspring's cognitive performance and synaptic plasticity in wild-type but not improve memory deficit in Alzheimer's mice.Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.The reemergence of long-term potentiation in aged Alzheimer's disease mouse model.Lidocaine attenuates cognitive impairment after isoflurane anesthesia in old rats.Acute blast injury reduces brain abeta in two rodent species.APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.Behavioral defects in chaperone-deficient Alzheimer's disease model mice.Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease
P2860
Q21144713-45A4F948-BFB5-4812-B400-3577109C8606Q22253023-2A374C5B-EB6D-4E51-9C3D-C3E1DE1339D0Q24644293-A8737A72-42BB-493C-90DA-261A1228F7F9Q24651102-B60D9681-1ED8-471C-B432-2145BEF8284AQ24675823-E436A93B-9FA6-4C54-9B94-8EB8D5099BD6Q24679444-838A06AD-AE55-4396-9022-49BD99BE48DCQ24793976-F5AABA3F-4529-43BB-957E-0C08AF976363Q24803797-1CAE15CA-D334-4A83-A2AB-6ADAFDF78F9FQ26745928-83AEE90D-3FEB-422B-A821-EA9D77A56CFFQ26752246-1B7A794B-F631-493C-8303-F26D7DD6AB0EQ26771808-F16D7D80-C4A7-4463-856D-521E1AD5BFF9Q27307826-212F6047-A8D5-4056-A23D-5960241C29A9Q27307877-709AD462-EB08-42B4-91F4-A369F9CA4532Q27307991-6E3F3A93-8E07-44DF-A5F7-BCBE4E5D87F8Q27318742-E7BF80BD-1451-4B26-A931-A5DC6FA8092FQ27323997-9D14C7D8-63D5-4694-8ACA-30D70F2C71D6Q27340023-A07BED69-72C0-4DA0-89CC-47572E284A72Q27438189-2B860582-8DF9-4987-AE88-A8544CB3D274Q27649493-7E2C7C70-4084-40A2-9A72-96F158F21F13Q28111789-5991D66D-6A32-4988-ACE2-6F391B58EC44Q28315288-1B00A36C-9121-498E-BEC8-BA4238CE575AQ28389491-95AAB8DA-1CD2-473C-9B41-2E9AC52BE520Q28477320-F436B322-2EE4-4C9E-B360-5BD78AED718FQ28486102-A023C6E7-801D-4F4F-BD9C-1A25A15964B4Q28534524-F7E8B03D-1D7F-4303-86DC-561F4115D677Q28539753-836347B0-0747-4AF5-A348-1ABF06D2E875Q28592890-EF9D124C-F2AB-40B5-B265-CB93EDA09295Q28595059-265FC440-D3AA-42D9-BB8A-59FA81AE6D67Q28654400-A5BB6B34-7DDD-45C1-8BA9-8B9BC27EEEF8Q29417137-2FECA0CB-24DF-4561-B18A-8CF347367829Q29994749-444C2AF5-B6ED-4994-8F3C-50ECEDEA8366Q30052936-538235E8-9235-41D2-A3C2-21251BDFE31BQ30379588-D30BCCA9-70A8-430B-955A-2DDF4F73FC24Q30421873-E16E39EC-0701-4D4D-AA9C-FC02AE47C500Q30423253-9322F2C9-9AC3-4951-9027-1A8F3006B3C5Q30455082-CCCD8E88-1584-4C44-B98F-8D25C272EE25Q30471693-6E3419FD-A10B-48A5-8263-A9A6805CDF8FQ30476539-D4D16E88-1FF4-449A-AEE4-AC0FC76ED907Q30481236-2641FE5A-0EBD-4009-A646-626AEF531BBDQ30483386-EE1B56B0-1B36-49B3-ACFA-78D1BEA5AC4C
P2860
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Age-dependent changes in brain ...... model of Alzheimer's disease.
@ast
Age-dependent changes in brain ...... model of Alzheimer's disease.
@en
type
label
Age-dependent changes in brain ...... model of Alzheimer's disease.
@ast
Age-dependent changes in brain ...... model of Alzheimer's disease.
@en
prefLabel
Age-dependent changes in brain ...... model of Alzheimer's disease.
@ast
Age-dependent changes in brain ...... model of Alzheimer's disease.
@en
P2093
P1476
Age-dependent changes in brain ...... e model of Alzheimer's disease
@en
P2093
L H Younkin
S G Younkin
T Kawarabayashi
P304
P356
10.1523/JNEUROSCI.21-02-00372.2001
P407
P577
2001-01-01T00:00:00Z